BioAge Labs, Inc (BIOA)
Healthcare
Drug Manufacturers - Specialty & Generic
—
9.00 $
-63.6%
vs. previous close
Closing price · As of: 31. Jul 2026
BioAge Labs, Inc (BIOA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -24 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -11 | -7.8 | -8.5 | -16 | -16 | -15 | -5.1 | -17 | -20 | -16 | -28 | -24 | -88 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.2 | |
| 0.8 | 0.8 | 0.8 | 0.9 | 1.6 | 1.8 | 2.7 | 2.9 | 3.2 | 2.8 | 2.7 | 4.3 | 13 | |
| 1.2 | 1.3 | 4.5 | -4.7 | -3.9 | 6.2 | 14 | -7.5 | -1.8 | 1.2 | -3.7 | -6.0 | -10 | |
| 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.4 | 0.2 | 0.0 | 0.1 | 0.0 | 0.3 | |
| -0.1 | -0.1 | – | – | 0.0 | -0.3 | 0.0 | -78 | -16 | 13 | -14 | -47 | -64 | |
| – | – | – | – | – | -1.5 | -1.5 | -1.5 | -1.5 | -1.5 | -1.5 | -1.5 | -6.0 | |
| 12 | 0.0 | -1.0 | 168 | -2.4 | 191 | 25 | -1.5 | -1.5 | -1.5 | 16 | 124 | 137 | |
| 1.4 | -7.9 | -9.6 | 152 | -18 | 175 | 20 | -97 | -37 | -4.8 | -27 | 53 | -16 | |
| -11 | -7.9 | -8.5 | -16 | -16 | -15 | -5.2 | -18 | -20 | -16 | -28 | -24 | -89 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.